Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:associated_with |
increased transmissibility
severe disease |
| gptkbp:characteristics |
RNA virus
enveloped virus positive-sense single-stranded RNA SARS-Co V-2 virus |
| gptkbp:data_usage |
higher than original strain
|
| gptkbp:descendant |
B.1.1.7 lineage
|
| gptkbp:discovered_by |
gptkb:United_Kingdom
|
| gptkbp:exported_to |
multiple countries
|
| gptkbp:genetic_diversity |
gptkb:N501_Y
P681 H del69-70 SARS-Co V-2 genome |
| gptkbp:healthcare |
gptkb:quarantine_measures
travel restrictions healthcare system strain increased testing |
| https://www.w3.org/2000/01/rdf-schema#label |
SARS-Co V-2 B.1.1.7
|
| gptkbp:is_monitored_by |
public health agencies
WHO guidelines CDC guidelines |
| gptkbp:is_protected_by |
vaccination
mask-wearing social distancing |
| gptkbp:is_recognized_by |
September 2020
|
| gptkbp:is_vulnerable_to |
reduced effectiveness
|
| gptkbp:origin |
gptkb:SARS-Co_V-2
|
| gptkbp:research |
gptkb:healthcare_organization
clinical trials immune response epidemiological studies contact tracing public health interventions vaccine development viral evolution transmission dynamics variant characteristics viral load studies |
| gptkbp:research_focus |
treatment efficacy
vaccine adaptation |
| gptkbp:scientific_classification |
Variant of Concern
|
| gptkbp:side_effect |
mortality rates
hospitalization rates |
| gptkbp:social_responsibility |
global pandemic
|
| gptkbp:symptoms |
COVID-19 symptoms
|
| gptkbp:track |
genomic surveillance
|
| gptkbp:treatment |
supportive care
monoclonal antibodies antiviral medications |
| gptkbp:bfsParent |
gptkb:Alpha_variant
|
| gptkbp:bfsLayer |
5
|